Eversense 365 積極血糖監測系統 (CGM)
K 號：K241335 · 2024-09-16
廣告
器材摘要
Eversense 365 Continuous Glucose Monitoring (CGM) System is the device name listed in this FDA 510(k) record. The listed applicant is Senseonics, Incorporated. It received FDA 510(k) clearance on 2024-09-16 under 510(k) number K241335. The device is classified under product code SBA. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.
常見問題
What is the Eversense 365 Continuous Glucose Monitoring (CGM) System?
Eversense 365 Continuous Glucose Monitoring (CGM) System is a medical device that received FDA 510(k) clearance on 2024-09-16. The listed applicant is Senseonics, Incorporated. The 510(k) number is K241335.
When did Eversense 365 Continuous Glucose Monitoring (CGM) System receive FDA 510(k) clearance?
Eversense 365 Continuous Glucose Monitoring (CGM) System received FDA 510(k) clearance on 2024-09-16, under 510(k) number K241335.
Who is the listed applicant for Eversense 365 Continuous Glucose Monitoring (CGM) System?
The FDA 510(k) record lists Senseonics, Incorporated as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Eversense 365 Continuous Glucose Monitoring (CGM) System?
The FDA product code for Eversense 365 Continuous Glucose Monitoring (CGM) System is SBA.
相關臨床試驗
相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係，請查閱連結的官方來源。
官方來源
在 FDA 資料庫中查看 →資料來源為 FDA Open API。如需最新且權威的資訊，請始終參閱官方記錄。
廣告